Biotech news
Pharma
Patentees should ensure their applications meet the plausibility standard right from the start, says Iain Armstrong of HGF, who investigates one of the
developing challenges facing patentability in the life sciences field. 24 October 2017
Americas
If biotech companies in Brazil understand that they can use both plant variety and patent protection in certain cases, their ability to innovate may improve, says Gabriel Di Blasi of Di Blasi, Parente & Associados. 24 October 2017
Americas
The Broad Institute of Harvard and MIT has signed a patent licensing deal with DuPont Pioneer to provide CRISPR/Cas9 technology to agricultural researchers and producers. 19 October 2017
Pharma
The House of Lords is hearing from companies and regulators today on issues including the government’s life sciences strategy and Brexit’s impact on the industry. 17 October 2017
Americas
Allergan has until tomorrow, Friday October 13, to address the question of whether its patent licensing deal with a Native American tribe was a sham. 12 October 2017
Americas
US-based law firm Phelps Dunbar has appointed Fenita Morris-Shepard as a counsel in its life sciences practice. 10 October 2017
Biotech
Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir. 9 October 2017
Americas
Hospira has appealed against a verdict which saw Amgen secure $70 million in damages over a biosimilar dispute between the two companies. 2 October 2017
Americas
AbbVie has settled its patent dispute over Amgen’s proposed biosimilar for Humira (adalimumab), a drug used to treat multiple types of arthritis as well as psoriasis. 29 September 2017
Americas
Unlike in Europe, the lack of a plausibility threshold in the US means that those applying for patents there are more likely to be granted a broader claim. 28 September 2017